Abbisko Therapeutics Co., Ltd.
USPTO PatentsView assignee record - 9 granted patents across 6 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Abbisko ranks #27,958 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 6 technology areas.
- #27,958
- of 49,997 US assignees by volume
- 29th percentile
- by Innovation Score (28.9/100)
- 9.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R27958 · Foreign Corporation #27,958 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 9 grants
- MID-PACK #27,958/49,997
- PHOTO-FINISH Aarbakke Innovation…
- CPC-NARROW A61P · 6 areas
- INNOV-THIN 28.9/100
- CLAIMS-PAR 9.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Aarbakke Innovation, A.S. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Abbisko’s 28.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Abbisko
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Corex Materials · near 29
Corex Materials · near
29 score
- RF DSP · near 29
RF DSP · near
29 score
- Abbisko Therapeutics · this assignee 29
Abbisko Therapeutics · this assignee
29 score
- Alof Media · near 29
Alof Media · near
29 score
- Qatar University… · near 29
Qatar University… · near
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Abbisko's Innovation Score is 28.9/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Abbisko?
Each dot is one of Abbisko’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbisko’s own 9.4 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Abbisko's grants concentrate
Abbisko Therapeutics Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2023. By volume, Abbisko sits between Aarbakke Innovation, A.S. and Acandis GMBH & Co. KG.
Abbisko's three-year grant acceleration
Abbisko Therapeutics Co., Ltd. shows 4 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Abbisko's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Aarbakke Innovati…
Aarbakke Innovation, A.S.
9 patents
- AB Medica S P A
AB Medica S.P.A.
9 patents
- Abaxx
Abaxx Technologies Corp.
9 patents
- ABB Turbo Systems
ABB Turbo Systems AG
9 patents
- Abclon
Abclon Inc.
9 patents
- ABM Italia S P A
ABM Italia S.P.A.
9 patents
- AC Avalanche
AC Avalanche, LLC
9 patents
- Acandis & KG
Acandis GMBH & Co. KG
9 patents
- Abbisko Therapeut… ◀
Abbisko Therapeutics Co., Ltd.
9 patents
What this shows Abbisko holds 9 patents at rank #27,959, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Abbisko
By rank, the assignees closest to #27,959 in granted patent volume.
- Aarbakke Innovation, A.S. #27,955 · 9 patents
- AB Medica S.P.A. #27,956 · 9 patents
- Abaxx Technologies Corp. #27,957 · 9 patents
- ABB Turbo Systems AG #27,958 · 9 patents
- Abclon Inc. #27,960 · 9 patents
- ABM Italia S.P.A. #27,961 · 9 patents
- AC Avalanche, LLC #27,962 · 9 patents
- Acandis GMBH & Co. KG #27,963 · 9 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Abbisko's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Abbisko, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Abbisko ranks #2,057 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (29 here).
Abbisko's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 29th percentile higher than 29% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 4 | 44.4% |
| 2022 | 2 | 22.2% |
| 2023 | 1 | 11.1% |
| 2024 | 1 | 11.1% |
| 2025partial year | 1 | 11.1% |
Which technologies does Abbisko Therapeutics Co., Ltd. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Abbisko Therapeutics Co., Ltd.'s patent record in context - here's where to go next.
- Abbisko Therapeutics Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #27,958 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Abbisko Therapeutics Co., Ltd. against Aarbakke Innovation, A.S., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.